Philip Morris CR A.S. (TABAK) - Net Assets
Based on the latest financial reports, Philip Morris CR A.S. (TABAK) has net assets worth Kč8.21 Billion CZK (≈ $393.93 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Kč17.54 Billion ≈ $841.34 Million USD) and total liabilities (Kč9.33 Billion ≈ $447.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. For live market cap and overall valuation, see Philip Morris CR A.S. stock valuation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Kč8.21 Billion |
| % of Total Assets | 46.82% |
| Annual Growth Rate | -2.28% |
| 5-Year Change | -5.78% |
| 10-Year Change | N/A |
| Growth Volatility | 3.16 |
Philip Morris CR A.S. - Net Assets Trend (2019–2025)
This chart illustrates how Philip Morris CR A.S.'s net assets have evolved over time, based on quarterly financial data.
Annual Net Assets for Philip Morris CR A.S. (2019–2025)
The table below shows the annual net assets of Philip Morris CR A.S. from 2019 to 2025. See how leveraged is Philip Morris CR A.S.'s balance sheet to measure how much of total assets are equity-financed.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Kč8.21 Billion ≈ $393.93 Million |
-3.67% |
| 2024-12-31 | Kč8.53 Billion ≈ $408.94 Million |
+0.11% |
| 2023-12-31 | Kč8.52 Billion ≈ $408.51 Million |
-2.84% |
| 2022-12-31 | Kč8.77 Billion ≈ $420.45 Million |
+0.56% |
| 2021-12-31 | Kč8.72 Billion ≈ $418.10 Million |
+0.66% |
| 2020-12-31 | Kč8.66 Billion ≈ $415.37 Million |
-8.21% |
| 2019-12-31 | Kč9.44 Billion ≈ $452.54 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Philip Morris CR A.S.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 28.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Kč3.08 Billion | 37.49% |
| Other Components | Kč5.13 Billion | 62.51% |
| Total Equity | Kč8.21 Billion | 100.00% |
Philip Morris CR A.S. Competitors by Market Cap
The table below lists competitors of Philip Morris CR A.S. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lechwerke AG
F:LEC
|
$2.48 Billion |
|
IJM Corporation Bhd
KLSE:3336
|
$2.48 Billion |
|
Corporativo Fragua S.A.B. de C.V
MX:FRAGUAB
|
$2.48 Billion |
|
Guangdong Topstar Technology Co Ltd
SHE:300607
|
$2.48 Billion |
|
LCI Industries
NYSE:LCII
|
$2.48 Billion |
|
Artois Nom.
PA:ARTO
|
$2.48 Billion |
|
Winner Medical Co Ltd
SHE:300888
|
$2.48 Billion |
|
Banque Cantonale du Valais
SW:WKBN
|
$2.48 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Philip Morris CR A.S.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,525,000,000 to 8,212,000,000, a change of -313,000,000 (-3.7%).
- Net income of 3,035,000,000 contributed positively to equity growth.
- Dividend payments of 743,000,000 reduced retained earnings.
- Other factors decreased equity by 2,605,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Kč3.04 Billion | +36.96% |
| Dividends Paid | Kč743.00 Million | -9.05% |
| Other Changes | Kč-2.60 Billion | -31.72% |
| Total Change | Kč- | -3.67% |
Book Value vs Market Value Analysis
This analysis compares Philip Morris CR A.S.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.30x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 5.48x to 6.30x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | Kč3436.31 | Kč18840.00 | x |
| 2020-12-31 | Kč3154.02 | Kč18840.00 | x |
| 2021-12-31 | Kč3174.78 | Kč18840.00 | x |
| 2022-12-31 | Kč3192.63 | Kč18840.00 | x |
| 2023-12-31 | Kč3101.93 | Kč18840.00 | x |
| 2024-12-31 | Kč3105.21 | Kč18840.00 | x |
| 2025-12-31 | Kč2991.20 | Kč18840.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Philip Morris CR A.S. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 36.96%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.00%
- • Asset Turnover: 1.24x
- • Equity Multiplier: 2.14x
- Recent ROE (36.96%) is below the historical average (40.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 42.61% | 23.52% | 1.04x | 1.74x | Kč3.08 Billion |
| 2020 | 40.72% | 19.72% | 1.11x | 1.87x | Kč2.66 Billion |
| 2021 | 40.34% | 18.64% | 1.06x | 2.04x | Kč2.64 Billion |
| 2022 | 41.47% | 17.35% | 1.28x | 1.87x | Kč2.76 Billion |
| 2023 | 39.26% | 16.25% | 1.29x | 1.87x | Kč2.49 Billion |
| 2024 | 39.23% | 15.48% | 1.25x | 2.03x | Kč2.49 Billion |
| 2025 | 36.96% | 14.00% | 1.24x | 2.14x | Kč2.21 Billion |
Industry Comparison
This section compares Philip Morris CR A.S.'s net assets metrics with peer companies in the Tobacco industry.
No peer company data available for comparison.
About Philip Morris CR A.S.
Philip Morris CR a.s., through its subsidiary, Philip Morris Slovakia s.r.o., manufactures and markets tobacco products under the Marlboro, L&M, Philip Morris, Petra Klasik, and Sparta brands in the Czech Republic, the Slovak Republic, and internationally. It offers cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products. The company was founded in 1812 … Read more